Bacteria: Gram-Negative Cocci Flashcards
What is the gram negative cocci
- Neisseria meningitidis
2. Neisseria Gonorrhoeae
Neisseria meningitidis and gonorrhoeae bacteria are
- gram-negative
- diplococci
- oxidase positive
chocolate agar (heated blood agar) is required for growth of
Neisseria meningitidis and gonorrhoeae
the antimicrobials vancomycin, polymyxin (colistin), and nystatin (VPN) are included in
Thayer-Martin agar
Thayer-Martin agar
encourages the growth of Neisseria meningitidis and gonorrhoeae while inhibiting the growth of other microorganisms
Thayer-Martin agar is comprised of
the antimicrobials vancomycin, polymyxin (colistin), and nystatin (VPN), which encourage the growth of Neisseria meningitidis and gonorrhoeae while inhibiting the growth of other microorganisms
Deficiency in the terminal complement components C5-C9 (which form the membrane attack complex (MAC)) results in increased susceptibility to
Neisseria meningitidis and gonorrhoeae infection
The pili of Neisseria meningitidis and gonorrhoeae bacteria display
antigenic variation (due to frequent genetic rearrangement)
The IgA protease of Neisseria meningitidis and gonorrhoeae bacteria
cleaves secretory IgA (found on mucosal surfaces) at the hinge region
Neisseria meningitidis is easily
spread in close quarters, such as college dorms
Important characteristics of Neisseria meningitidis bacteria include:
- gram-negative
- diplococci morphology
- oxidase-positive
- growth on chocolate agar
- growth on Thayer-Martin (VPN) agar
- higher infection rates in patients with C5-C9 complement deficiency (absence of MAC)
- production of an IgA protease, and fimbriae/pili that demonstrate antigenic variation
- encapsulated
Neisseria meningitidis bacteria are able to
ferment both glucose and maltose (in contrast to Neisseria gonorrhoeae, which can only ferment glucose)
Neisseria meningitidis is transmitted via
respiratory droplets (typically from nasopharyngeal colonization of asymptomatic carriers)
Meningococcal vaccines include
antigens contained in the polysaccharide capsule of Neisseria meningitidis (the polysaccharide quadrivalent or conjugate vaccine)
Neisseria meningitidis subtype B causes
⅓ of meningococcal disease in the US because vaccines against subtype B have only recently become available